Transactions
10
Insider / BALCHEM CORP
van Gunsteren Job Leonard
SVP and GM, Specialty Products at BALCHEM CORP
- Company
- BALCHEM CORP
- Ticker
- BCPC
- First filing on record
- December 5, 2025
- Latest trade on record
- February 12, 2026
- SEC filings
- EDGAR ↗
van Gunsteren Job Leonard, SVP and GM, Specialty Products at BALCHEM CORP, has disclosed 10 transactions in BCPC since December 5, 2025: 0 purchases (0 open-market buys) and 5 sales, worth about $1.5M at the reported prices. The latest was filed February 13, 2026, 2 days after the trade.
Open-market buys
0
Sales
5
Avg. disclosure lag
1.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months van Gunsteren Job Leonard made no purchases and 5 sales worth $1.1M, plus 5 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
van Gunsteren Job Leonard has traded 1 stock on record; the largest by dollars is BCPC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 3,375 | — |
| F | Shares withheld for tax | 3 | 1,072 | $190K |
| M | Option exercise or conversion | 2 | 12,000 | $365K |
| S | Open-market sale | 2 | 6,000 | $920K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 6 | 0 | 3 · $190K |
| 2025 | 4 | 0 | 2 · $920K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| BCPC | Other A | February 11, 2026 | February 13, 2026 | 2d | 1,600 | — | — | derivative | Form 4 ↗ | |
| BCPC | Sell F | February 12, 2026 | February 13, 2026 | 1d | 58 | $177 | $10K | Form 4 ↗ | ||
| BCPC | Sell F | February 11, 2026 | February 13, 2026 | 2d | 756 | $179 | $135K | Form 4 ↗ | ||
| BCPC | Other A | February 11, 2026 | February 13, 2026 | 2d | 1,345 | — | — | Form 4 ↗ | ||
| BCPC | Other A | February 11, 2026 | February 13, 2026 | 2d | 430 | — | — | Form 4 ↗ | ||
| BCPC | Sell F | February 8, 2026 | February 10, 2026 | 2d | 258 | $173 | $45K | Form 4 ↗ | ||
| BCPC | Option / conversion M | December 4, 2025 | December 5, 2025 | 1d | 6,000 | — | — | derivative | Form 4 ↗ | |
| BCPC | Sell S | December 4, 2025 | December 5, 2025 | 1d | 1,765 | $154 | $271K | Form 4 ↗ | ||
| BCPC | Sell S | December 4, 2025 | December 5, 2025 | 1d | 4,235 | $153 | $648K | Form 4 ↗ | ||
| BCPC | Option / conversion M | December 4, 2025 | December 5, 2025 | 1d | 6,000 | $61 | $365K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| February 13, 2026 | Form 4 | 0001140361-26-005544 | 5 | published | EDGAR ↗ |
| February 10, 2026 | Form 4 | 0001140361-26-004614 | 1 | published | EDGAR ↗ |
| December 5, 2025 | Form 4 | 0001140361-25-044551 | 4 | published | EDGAR ↗ |
Other insiders at BALCHEM CORP
- Fischer David B Director 12 rows
- Harris Theodore L Director 8 rows
- Backus William A. VP & Chief Accounting Officer 7 rows
- Boned Frederic SVP/GM, Human Nutri. & Health 7 rows
- Reid Martin Luther SVP Chief Supply Chain Officer 7 rows
- Bengtsson Carl Martin EVP & Chief Financial Officer 6 rows
- Miyata Hatsuki EVP, CLO, & Secretary 6 rows
- Tignor Michael Brent SVP & Chief HR Officer 6 rows
- Graham George SVP and Chief R&D Officer 3 rows
- Fish Kathleen B Director 1 row
Everyone on file, with contracts and lobbying under the company's name: BALCHEM CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 10 | December 5, 2025 | February 13, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.